ConductScience.org, home

Paper6445274

Pharmacokinetics of zimelidine. Systemic availability of zimelidine and norzimelidine in human volunteers.

Brown D and 5 others. Eur J Clin Pharmacol, 1980. Cited by 37 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Pharmacokinetics of zimelidine. Systemic availability of zimelidine and norzimelidine in human volunteers. Papers, record 6445274. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6445274

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacokinetics of zimelidine. Systemic availability of zimelidine and norzimelidine in human volunteers.
PubMed
Journal
Eur J Clin Pharmacol
PubMed
Year
1980
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
37
iCite
Relative citation ratio, by iCite
2.59
iCite
Revised in PubMed
2019-08-13
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Brown DD
2Scott DHD H
3Scott DBD B
4Meyer MM
5Westerlund DD
6Lundström JJ

Source PubMed

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antidepressive AgentsMajor topic
BrompheniramineMajor topic
PyridinesMajor topic
Administration, Oral
Adult
Biological Availability
Dealkylation
Electrocardiography
Humans
Injections, Intravenous
Male
Time Factors
Zimeldine

Source PubMed

References7

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1834,363Inhibition of the neuronal uptake of 5-hydroxytryptamine and noradrenaline in rat brain by (Z)- and (E)-3-(4-bromophenyl)-N,N-dimethyl-3-(3-pyridyl) allylamines and their secondary analogues.Neuropharmacology1977https://conductscience.org/library/papers/834363PubMed
2113,803Zimelidine: a therapeutic and pharmacokinetic study in depression.Psychopharmacology (Berl)1979https://conductscience.org/library/papers/113803PubMed
31,173,529Tricyclic antidepressant agents. II. Effect of oral administration on the uptake of 3-H-noradrenaline and 14-C-5-hydroxytryptamine in slices of the midbrain-hypothalamus region of the rat.Acta Pharmacol Toxicol (Copenh)1975https://conductscience.org/library/papers/1173529PubMed
41,173,528
Tricyclic antidepressant agents. I. Comparison of the inhibition of the uptake of 3-H-noradrenaline and 14-C-5-hydroxytryptamine in slices and crude synaptosome preparations of the midbrain-hypothalamus region of the rat brain.
Acta Pharmacol Toxicol (Copenh)1975https://conductscience.org/library/papers/1173528PubMed
5947,293(Z)-dimethylamino-1-(4-bromophenyl)-1-(3-pyridyl) propene (h 102/09), a new selective inhibitor of the neuronal 5-hydroxytryptamine uptake.Acta Pharmacol Toxicol (Copenh)1976https://conductscience.org/library/papers/947293PubMed
65,567,579Influence of first-pass effect on availability of drugs on oral administration.J Pharm Sci1971https://conductscience.org/library/papers/5567579PubMed
76,450,684Biochemical effects of zimelidine in man.Eur J Clin Pharmacol1980https://conductscience.org/library/papers/6450684PubMed

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.

PMIDTitleJournalYearIn PapersSource
6,768,073Inhibition of 5-hydroxytryptamine uptake in human platelets by antidepressant agents in vivo.Psychopharmacology (Berl)1980https://conductscience.org/library/papers/6768073PubMed
6,455,297Pharmacokinetics of zimelidine in humans--plasma levels and urinary excretion of zimelidine and norzimelidine after intravenous and oral administration of zimelidine.Eur J Clin Pharmacol1981https://conductscience.org/library/papers/6455297PubMed
6,228,368Pharmacokinetic study of zimelidine using a new GLC method.Clin Pharmacokinet1983https://conductscience.org/library/papers/6228368PubMed
6,226,335Possible hepatotoxicity of zimelidine.Br Med J (Clin Res Ed)1983https://conductscience.org/library/papers/6226335PubMed
6,215,240Zimelidine: a review of its pharmacological properties and therapeutic efficacy in depressive illness.Drugs1982https://conductscience.org/library/papers/6215240PubMed
6,164,072Effects of zimelidine on serotoninergic and noradrenergic neurons after repeated administration in the rat.Psychopharmacology (Berl)1981https://conductscience.org/library/papers/6164072PubMed
3,161,742Influence of renal failure on the kinetics of zimeldine and norzimelidine.Eur J Clin Pharmacol1985https://conductscience.org/library/papers/3161742PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6445274

GET https://conductscience.org/api/papers/v1/6445274/authors